Another study showed that the methylation of the promoter region of the H19 gene is associated with sorafenib resistance in HCC cell lines and that the overexpression of H19 sensitizes sorafenib resistance by suppressing cell growth after sorafenib treatment [165]. Here, H19 is linked to hepatocellular carcinoma.